India's pharma industry saves US healthcare $219 billion in 2022
Summary: India's pharmaceutical industry saved the US healthcare system $219 billion in 2022, according to Union Health Secretary Punya Salila Srivastava. India is the third-largest producer of generic medicines and has the most US FDA-approved pharmaceutical plants outside the US.
India manufactured 4 billion of the 8 billion vaccine doses produced globally last year. The country has also reformed medical education, increasing the number of medical and nursing colleges to address healthcare professional shortages.
India and the US are collaborating on health initiatives, including cancer research and pandemic preparedness. They have launched the US-India Cancer Moonshot Dialogue and the Bio-5 alliance to optimize the biopharmaceutical supply chain.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings